This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for a "QUADRUPLE RESONANCE INVERSE (QCI) DETECTION CRYOPROBE FOR HQC HCNP". The contract has a ceiling value of $383,068.32 and an ultimate completion date of May 1, 2022. The contract is not set aside for a specific business type. Bruker Biospin Corp has a history of providing specialized equipment, maintenance, and...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and equipment, for the delivery of a Cryo Probe for Nuclear Magnetic Resonance (NMR) analysis. The contract has a potential value of $187,725.00 and a completion date of December 31, 2020. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support...
This is a $93,143.40 fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for a Bruker Avance III 500 MHz NMR service contract. The contract has a period of performance through September 16, 2021 and is not associated with a larger contract vehicle or set-aside designation. Bruker Biospin Corp is a provider of nuclear magnetic resonance (NMR) spectrometers, maintenance, and support services to...
This is a $159,767.50 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for the provision of a Bruker Avance III 500 MHz Nuclear Magnetic Resonance (NMR) system. The contract has no set-aside designation and is for the service and maintenance of this specialized scientific equipment used by the FDA. Bruker Biospin Corp has a history of providing NMR systems, upgrades, and support services...
This $2,670,476.00 firm fixed price purchase order was awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments and provider of specialized equipment, maintenance, and support services to U.S. federal government agencies. The contract is for the provision of nuclear magnetic resonance (NMR) spectrometers, upgrades, maintenance, and related support services. It does not have a set-aside designation. Bruker Biospin Corp has previously...
The Department of Health and Human Services Food and Drug Administration awarded a $879,190.00 firm fixed price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, to upgrade the agency's 500 and 700 MHz nuclear magnetic resonance (NMR) spectrometers. The contract, which does not have a set-aside designation, will provide new equipment, including a new cryoprobe, backup room temperature probe, and automated sample changers, to improve the sensitivity and...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services' Food and Drug Administration to Bruker Biospin Corp for maintenance of laboratory equipment. The $180,527.72 contract provides for a two-year agreement covering console, magnet, cryoplatform, and two cryoprobes used for nuclear magnetic resonance spectroscopy. Performance will take place at a laboratory in Jamaica, New York. As the prime and sole contractor, Bruker Biospin Corp will be responsible...
This is a firm fixed price purchase order for a cryo-cooling unit awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and provider of specialized equipment, maintenance, and support services to U.S. federal government agencies. The unit is for a Bruker NMR spectrometer system at the FDA's National Center for Toxicological Research. The potential value of the contract is $116,955.00 and there was no...
The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp a firm fixed price purchase order for $119,796.45 to provide preventive maintenance for an Advance III HD700 nuclear magnetic resonance spectrometer cryoprobe and CryoPlatform system AVHD700X located in Silver Spring, Maryland. The award has a period of performance through February 2025 and includes two optional one-year extension periods. This award responds to a sources sought notification...
The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp, a subsidiary of Bruker Corporation, a $110,097.30 firm-fixed-price purchase order to provide an automatic sample changer and compatible probe for a Bruker 400 MHz nuclear magnetic resonance (NMR) spectrometer. The award has an August 17, 2024 completion date and was made on September 16, 2022. Bruker Biospin Corp is a for-profit manufacturer of scientific instruments and equipment. The company...